Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | -6,651 | 3,208 | 33,971 | 2,702 |
| Gross Profit | N/A | -6,651 | 3,208 | 33,971 | 2,702 |
| Operating Expenses | 66,102 | 41,604 | 136,489 | 129,920 | 132,965 |
| Operating Income | -66,102 | -48,255 | -133,281 | -95,949 | -130,263 |
| Other Income | 18,390 | -5,170 | 128,991 | 185 | 1,569 |
| Pre-tax Income | -47,712 | -53,425 | -4,290 | -95,764 | -128,694 |
| Income Tax | 21 | 318 | 715 | 0 | N/A |
| Net Income Continuous | -47,733 | -53,743 | -5,005 | -95,764 | -128,694 |
| Net Income | $-47,733 | $-53,743 | $-5,005 | $-95,764 | $-128,694 |
| EPS Basic Total Ops | -5.12 | -153.96 | -1.62 | -31.12 | -50.36 |
| EPS Basic Continuous Ops | -5.12 | -153.96 | -1.57 | -31.16 | -50.42 |
| EPS Diluted Total Ops | -6.58 | -153.96 | -1.62 | -31.12 | -50.36 |
| EPS Diluted Continuous Ops | -4.94 | -153.96 | -1.57 | -31.16 | -50.42 |
| EPS Diluted Before Non-Recurring Items | -6.58 | -32.73 | -1.62 | -31.12 | -50.36 |
| EBITDA(a) | $-65,642 | $-47,669 | $-133,935 | $-86,702 | $-122,496 |